These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32901672)

  • 21. Efficacy of palonosetron versus ramosetron on preventing opioid-based analgesia-related nausea and vomiting after lumbar spinal surgery: a prospective, randomized, and double-blind trial.
    Roh GU; Yang SY; Shim JK; Kwak YL
    Spine (Phila Pa 1976); 2014 Apr; 39(9):E543-9. PubMed ID: 24480956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
    Wu F; Lin X; Yang Z; Sun Z; Zeng F; Heng J; Qu J; Zeng L; Yang N; Zhang Y
    Clin Lung Cancer; 2018 Nov; 19(6):e913-e918. PubMed ID: 30197265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens.
    Holder-Murray J; Esper SA; Boisen ML; Gealey J; Meister K; Medich DS; Subramaniam K
    Korean J Anesthesiol; 2019 Aug; 72(4):344-350. PubMed ID: 31096730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial.
    Wang DS; Hu MT; Wang ZQ; Ren C; Qiu MZ; Luo HY; Jin Y; Fong WP; Wang SB; Peng JW; Zou QF; Tan Q; Wang FH; Li YH
    JAMA Netw Open; 2021 Apr; 4(4):e215250. PubMed ID: 33835174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period.
    Hahm TS; Hwang JW; Kim WH; Oh EJ; Kim DK; Choi WJ; Kim YH; Ryu JH; Yoo BH; Yon JH
    J Anesth; 2015 Feb; 29(1):21-8. PubMed ID: 25037960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiemetic Efficacy of Palonosetron Compared with the Combination of Ondansetron and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gynaecological Surgery.
    Dey S; Chanu SM; Dev P; Borthakur M; Karim HMR; Yunus M
    Rom J Anaesth Intensive Care; 2021 Jul; 28(1):19-24. PubMed ID: 36846536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting.
    Green MS; Green P; Malayaman SN; Hepler M; Neubert LJ; Horrow JC
    Br J Anaesth; 2012 Nov; 109(5):716-22. PubMed ID: 22831888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomised Study To Compare Palonosetron With Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynecological Surgeries.
    Balyan R; Kumar S; Lalitha K; Aneja S; George J
    Cureus; 2022 Mar; 14(3):e23615. PubMed ID: 35505760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.
    Kovac AL; Eberhart L; Kotarski J; Clerici G; Apfel C;
    Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of dexamethasone on the incidence of postoperative nausea and vomiting in breast cancer patients with neoadjuvant chemotherapy].
    Li ZH; Liu D; He ZJ; Fan ZY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):685-9. PubMed ID: 26284410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy.
    Jung WS; Kim YB; Park HY; Choi WJ; Yang HS
    J Anesth; 2013 Jun; 27(3):396-401. PubMed ID: 23224788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Roila F; Ruggeri B; Ballatori E; Fatigoni S; Caserta C; Licitra L; Mirabile A; Ionta MT; Massidda B; Cavanna L; Palladino MA; Tocci A; Fava S; Colantonio I; Angelelli L; Ciuffreda L; Fasola G; Zerilli F
    Ann Oncol; 2015 Jun; 26(6):1248-1253. PubMed ID: 25743855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprepitant in a multimodal approach for prevention of postoperative nausea and vomiting in high-risk patients: is there such a thing as "too many modalities"?
    Hache JJ; Vallejo MC; Waters JH; Williams BA
    ScientificWorldJournal; 2009 Apr; 9():291-9. PubMed ID: 19412558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.
    Kusagaya H; Inui N; Karayama M; Fujisawa T; Enomoto N; Kuroishi S; Nakamura Y; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yamada T; Shirai T; Hayakawa H; Suda T
    Lung Cancer; 2015 Dec; 90(3):410-6. PubMed ID: 26791800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
    Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
    Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Study of Palonosetron with Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynaecological Surgeries.
    Balyan R; Kumar S; Lalitha K; Aneja S; George JS
    Rom J Anaesth Intensive Care; 2022 Jul; 29(1):32-40. PubMed ID: 36844958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antiemetic effect of intravenous palonosetron versus intravenous ondansetron in laparoscopic cholecystectomy: a randomized controlled trial.
    Laha B; Hazra A; Mallick S
    Indian J Pharmacol; 2013; 45(1):24-9. PubMed ID: 23543732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.